Zai Lab Limited
ZLAB
$33.80
$0.180.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 398.99M | 355.75M | 322.71M | 291.07M | 266.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 398.99M | 355.75M | 322.71M | 291.07M | 266.72M |
| Cost of Revenue | 281.26M | 294.10M | 275.45M | 270.32M | 251.86M |
| Gross Profit | 117.73M | 61.65M | 47.27M | 20.75M | 14.86M |
| SG&A Expenses | 298.74M | 298.75M | 300.08M | 288.29M | 281.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 681.11M | 693.96M | 676.64M | 668.43M | 643.29M |
| Operating Income | -282.12M | -338.21M | -353.92M | -377.36M | -376.57M |
| Income Before Tax | -257.10M | -270.85M | -298.33M | -338.95M | -334.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -257.10 | -270.85 | -298.33 | -338.95 | -334.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -257.10M | -270.85M | -298.33M | -338.95M | -334.62M |
| EBIT | -282.12M | -338.21M | -353.92M | -377.36M | -376.57M |
| EBITDA | -270.26M | -326.92M | -343.59M | -367.98M | -367.54M |
| EPS Basic | -25.92 | -27.80 | -30.69 | -35.00 | -34.61 |
| Normalized Basic EPS | -1.58 | -1.73 | -1.91 | -2.30 | -2.25 |
| EPS Diluted | -25.92 | -27.80 | -30.69 | -35.00 | -34.61 |
| Normalized Diluted EPS | -1.58 | -1.73 | -1.91 | -2.30 | -2.25 |
| Average Basic Shares Outstanding | 395.76M | 390.12M | 388.82M | 387.71M | 386.54M |
| Average Diluted Shares Outstanding | 39.58M | 39.01M | 38.88M | 38.77M | 38.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |